Company intelligence / Profile preview
MabVax Therapeutics
San Diego, California, United Statesprnewswire.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Phase 1
01
Overview
MabVax developed fully human monoclonal antibodies and vaccine-based therapies for the treatment of cancers expressing specific tumor-associated antigens. Its lead program was a fully human IgG1 mAb targeting sialyl Lewis A/CA19–9 for pancreatic and other cancers. Early clinical studies demonstrated safety, specificity to target antigen, and potential efficacy signals in Phase I trials. The company also advanced a PET imaging agent and a radioimmunotherapy into early clinical development.
- Therapeutic areas
- Oncology
- Modalities
- Monoclonal antibodies (mAbs)VaccinesRadioimmunotherapy
- Industry
- Biotech
02
Drug pipeline
8 assets7 more assets in the full pipeline.
Request access →03
Partnerships
Memorial Sloan Kettering Cancer CenterRockefeller UniversitySarah Cannon Research InstituteHonor HealthImaging Endpoints
Beyond the preview
Go deeper on MabVax Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MabVax Therapeutics.